mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Physical activity and energy expenditure in rheumatoid arthritis patients and matched controls

Henchoz Y et al. – Daily energy expenditure is significantly lower in RA patients compared with matched controls, mainly due to less moderate–intensity PAs performed. Disease activity and fatigue are important contributing factors. These points need to be addressed if promoting physical activity (PA) in RA patients is a health goal.

Methods
  • One hundred and ten patients with RA and 440 age– and sex–matched controls were included in this study.
  • Energy expenditure was assessed using the validated physical activity (PA) frequency questionnaire.
  • Disease–related scores included disease activity (DAS–28), functional status (HAQ), pain visual analogue scale (VAS) and fatigue VAS.
  • Total energy expenditure (TEE) and the amount of energy spent in low– (TEE–low), moderate– (TEE–mod) and high–intensity (TEE–high) PAs were calculated. Sedentariness was defined as expending <10% of TEE in TEE–mod or TEE–high activities.
  • Between–group comparisons were computed using conditional logistic regression.
  • The effect of disease–related scores on TEE was investigated using linear regression.

Results
  • TEE was significantly lower for RA patients compared with controls [2392 kcal/day (95% CI 2295, 2490) and 2494 kcal/day (2446, 2543), respectively, P = 0.003].
  • A significant difference was found between groups in TEE–mod (P = 0.015), but not TEE–low (P = 0.242) and TEE–high (P = 0.146).
  • All disease–related scores were significantly poorer in sedentary compared with active patients.
  • TEE was inversely associated with age (P < 0.001), DAS–28 (P = 0.032) and fatigue VAS (P = 0.029), but not with HAQ and pain VAS.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close